subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified

tested_intervention: unsure


subject: CHEBI:44185

object_name: Lymphoma, Low-Grade


subject: CHEBI:9168

subject_name: Sirolimus

object_name: T-Cell Lymphoma


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: mantle cell lymphoma

tested_intervention: yes


subject: CHEBI:9168

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:9168

object_name: diffuse large B-cell lymphoma


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Hodgkin Disease


subject: CHEBI:4305

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:4305


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: peripheral vascular disease


subject: UNII:LKC0U3A8NJ

object_name: peripheral arterial disease


subject: CHEBI:4026

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib


subject: CHEBI:6121

subject_name: Ketamine

object_name: Surgical procedure finding


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: iron deficiency anemia


subject: CHEBI:28915

subject_name: Fosfomycin


subject: PUBCHEM.COMPOUND:500216

subject_name: Bakuchiol

object_name: Solar elastosis


subject: PUBCHEM.COMPOUND:500216

object_name: Wrinkled structure


subject: PUBCHEM.COMPOUND:500216

object_name: Skin Wrinkling


subject: CHEBI:9168

object_name: pure red-cell aplasia


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: hypertension


subject: PUBCHEM.COMPOUND:25476

object_name: Hypertension, CTCAE


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: salivary gland carcinoma


subject: UNII:0JSR7Z0NB6

object_name: salivary gland cancer


subject: UMLS:C4085970


subject: UMLS:C4085970


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C1530450

subject_name: AMG 162


subject: GTOPDB:9615

object_name: lung cancer


subject: GTOPDB:9615

object_name: lung neoplasm


subject: GTOPDB:9615

object_name: lung carcinoma


subject: GTOPDB:9615

object_name: pancreatic neoplasm


subject: GTOPDB:9615

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:9615

object_name: malignant pancreatic neoplasm


subject: GTOPDB:9615

object_name: colon carcinoma


subject: GTOPDB:9615

object_name: colorectal cancer


subject: GTOPDB:9615

object_name: colon cancer


subject: GTOPDB:9615

object_name: Childhood Breast Carcinoma


subject: GTOPDB:9615

object_name: breast carcinoma


subject: GTOPDB:9615

object_name: breast cancer


subject: GTOPDB:9615

object_name: thyroid tumor


subject: GTOPDB:9615

object_name: thyroid gland carcinoma


subject: GTOPDB:9615

object_name: thyroid cancer


subject: GTOPDB:9615

object_name: ovarian cancer


subject: GTOPDB:9615

object_name: ovarian neoplasm


subject: GTOPDB:9615

object_name: ovarian carcinoma


subject: UMLS:C3658787

object_name: lung cancer


subject: UMLS:C3658787

object_name: lung neoplasm


subject: UMLS:C3658787

object_name: lung carcinoma


subject: UMLS:C3658787

object_name: pancreatic neoplasm


subject: UMLS:C3658787

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3658787

object_name: malignant pancreatic neoplasm


subject: UMLS:C3658787

object_name: colon carcinoma


subject: UMLS:C3658787

object_name: colorectal cancer


subject: UMLS:C3658787

object_name: colon cancer


subject: UMLS:C3658787

object_name: Childhood Breast Carcinoma


subject: UMLS:C3658787

object_name: breast carcinoma


subject: UMLS:C3658787

object_name: breast cancer


subject: UMLS:C3658787

object_name: thyroid tumor


subject: UMLS:C3658787

object_name: thyroid gland carcinoma


subject: UMLS:C3658787

object_name: thyroid cancer


subject: UMLS:C3658787

object_name: ovarian cancer


subject: UMLS:C3658787

object_name: ovarian neoplasm


subject: UMLS:C3658787

object_name: ovarian carcinoma


subject: UMLS:C4722367

object_name: lung cancer


subject: UMLS:C4722367

object_name: lung neoplasm


subject: UMLS:C4722367

object_name: lung carcinoma


subject: UMLS:C4722367

object_name: pancreatic neoplasm


subject: UMLS:C4722367

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4722367

object_name: malignant pancreatic neoplasm


subject: UMLS:C4722367

object_name: colon carcinoma


subject: UMLS:C4722367

object_name: colorectal cancer


subject: UMLS:C4722367

object_name: colon cancer


subject: UMLS:C4722367

object_name: Childhood Breast Carcinoma


subject: UMLS:C4722367

object_name: breast carcinoma


subject: UMLS:C4722367

object_name: breast cancer


subject: UMLS:C4722367

object_name: thyroid tumor


subject: UMLS:C4722367

object_name: thyroid gland carcinoma


subject: UMLS:C4722367

object_name: thyroid cancer


subject: UMLS:C4722367

object_name: ovarian cancer


subject: UMLS:C4722367

object_name: ovarian neoplasm


subject: UMLS:C4722367

object_name: ovarian carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: radiation pneumonitis


subject: UNII:28X28X9OKV

object_name: Non-small cell lung cancer stage II


subject: UNII:28X28X9OKV

object_name: Metastatic non-small cell lung cancer


subject: UNII:28X28X9OKV

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:28X28X9OKV

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:28X28X9OKV

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438

object_name: Non-small cell lung cancer stage III


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: PUBCHEM.COMPOUND:135423438


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin

object_name: Hypercholesterolemia


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: CHEBI:35341

subject_name: steroid

object_name: Pain at the lateral aspect of the elbow


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: hyperglycemia


subject: CHEBI:32682

subject_name: L-argininium

object_name: heart failure


subject: CHEBI:32682

object_name: Heart Failure, CTCAE


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: PUBCHEM.COMPOUND:53356543

subject_name: Camicinal

object_name: gastroparesis


subject: PUBCHEM.COMPOUND:53356543

object_name: Gastroparesis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4594481

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL4594481

object_name: neoplasm


subject: UMLS:C2698139


subject: UMLS:C2698139


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666876

object_name: Adult Solid Neoplasm


subject: UMLS:C5666876

object_name: Solid Neoplasm


subject: CHEBI:90863

subject_name: Sonidegib

object_name: medulloblastoma


subject: CHEBI:90863

object_name: childhood medulloblastoma


subject: CHEBI:90863

object_name: adult medulloblastoma


subject: UMLS:C4505505

object_name: trigeminal neuralgia


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:5001

object_name: metabolic syndrome X


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: bipolar disorder


subject: CHEBI:46245

object_name: bipolar depression


subject: CHEBI:134710

subject_name: Faropenem medoxomil

object_name: chronic bronchitis


subject: CHEBI:134710

object_name: bronchitis


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:168396

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:166895

subject_name: procyanidin

object_name: Spermatogenesis and semen disorders


subject: CHEBI:166895

object_name: DNA Breaks, Double-Stranded


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: Acute Ischemic Stroke


subject: CHEBI:177504

object_name: Ischemic stroke


subject: PR:000005679

subject_name: bifunctional coenzyme A synthase


subject: PR:000005679


subject: PR:000011476

subject_name: cytosolic Fe-S cluster assembly factor NUBP1


subject: PR:000011476


subject: PUBCHEM.COMPOUND:34698

subject_name: Teniposide

object_name: hemophagocytic syndrome


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Small cell lung cancer extensive stage


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: Pseudomonas aeruginosa infection


subject: PUBCHEM.COMPOUND:49863420

object_name: pneumonia


subject: PUBCHEM.COMPOUND:49863420

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:49863420

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:49863420

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:49863420

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:231683

subject_name: Anakinra

object_name: mucocutaneous lymph node syndrome


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:135515

subject_name: Bendamustine

object_name: B-cell neoplasm


subject: CHEBI:135515

object_name: immune system disorder


subject: CHEBI:135515

object_name: lymphoid system disorder


subject: CHEBI:135515

object_name: Lymphadenopathy


subject: CHEBI:135515

object_name: immunoproliferative disorder


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:137706467

object_name: lymphoma


subject: PUBCHEM.COMPOUND:137706467

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: PUBCHEM.COMPOUND:157088853

subject_name: Reamberin

object_name: Toxic effect of ethyl alcohol


subject: CHEBI:167574

subject_name: Semaglutide

object_name: cocaine use disorder


subject: CHEBI:167574

object_name: HIV infection


subject: GTOPDB:12962

subject_name: sotatercept

object_name: Cooley's anemia


subject: GTOPDB:12962

object_name: beta thalassemia


subject: GTOPDB:12962

object_name: beta-thalassemia intermedia


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: PUBCHEM.COMPOUND:2877953


subject: PUBCHEM.COMPOUND:2877953


subject: PUBCHEM.COMPOUND:2877953


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3896806


subject: UMLS:C3465373

subject_name: Toothpaste Product

object_name: Dental Plaque


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: prostate carcinoma


subject: UMLS:C3898831

object_name: prostate cancer


subject: UMLS:C3898831

object_name: prostate adenocarcinoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:70839

object_name: Embolism, Tumor


subject: CHEBI:70839

object_name: Neoplasm Metastasis


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:50172

subject_name: acitretin

object_name: Depressed mood


subject: CHEBI:50172

object_name: Cancer patients and suicide and depression


subject: CHEBI:50172

object_name: Depressed - symptom


subject: CHEBI:50172

object_name: Depression, CTCAE


subject: CHEBI:50172

object_name: liver disorder


subject: CHEBI:50172

object_name: hyperlipidemia


subject: CHEBI:50172

object_name: Dry skin


subject: CHEBI:50174


subject: CHEBI:50174


subject: CHEBI:50174


subject: CHEBI:50174


subject: CHEBI:50174


subject: CHEBI:50174


subject: CHEBI:50174


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: thyroid gland carcinoma


subject: UMLS:C1881373

object_name: thyroid cancer


subject: UMLS:C1881373

object_name: postsurgical hypothyroidism


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Chronic small plaque psoriasis


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: cardiovascular disorder


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UNII:8W6Q67R6NX

subject_name: Adrabetadex

object_name: Niemann-Pick disease type C


subject: UNII:8W6Q67R6NX

object_name: Niemann-Pick disease, type C1


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN

object_name: urticaria


subject: UNII:851NLB57HQ

object_name: reported urticaria (physical finding)


subject: UNII:851NLB57HQ

object_name: Urticaria, CTCAE


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:4710


subject: CHEBI:4710


subject: PUBCHEM.COMPOUND:146361282

object_name: ectopic ACTH secretion syndrome


subject: PUBCHEM.COMPOUND:146361282

object_name: Cushing Disease


subject: PUBCHEM.COMPOUND:146361282

object_name: Cushing syndrome


subject: PUBCHEM.COMPOUND:146361282

object_name: adrenal gland hyperfunction


subject: PUBCHEM.COMPOUND:146361282

object_name: hyperaldosteronism


subject: UNII:NR57FH6U1N

subject_name: ATUMELNANT


subject: UNII:NR57FH6U1N


subject: UNII:NR57FH6U1N


subject: UNII:NR57FH6U1N


subject: UNII:NR57FH6U1N


subject: UMLS:C3275040

object_name: coronary artery disorder


subject: UMLS:C3275040

object_name: coronary atherosclerosis


subject: UMLS:C1173246

object_name: hepatitis C


subject: UMLS:C1173246

object_name: chronic hepatitis C virus infection


subject: UMLS:C3886694

subject_name: Glucerna SR

object_name: type 2 diabetes mellitus


subject: UMLS:C3886694

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3886694

object_name: obesity


subject: UMLS:C3886694

object_name: Obesity, CTCAE


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: poikiloderma with neutropenia


subject: UNII:420K487FSG

object_name: prurigo nodularis


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:49668

object_name: breast carcinoma


subject: CHEBI:49668

object_name: breast cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: pediatric lymphoma


subject: CHEBI:9555

subject_name: Tioguanine

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:95043

object_name: acute lymphoblastic leukemia


subject: CHEBI:95043


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:45783

subject_name: Imatinib

object_name: Advanced Melanoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564

object_name: melanoma


subject: UMLS:C5854389

subject_name: Ultra-micronized Palmitoyl Ethylamine (PEA) FSD-201

object_name: mast cell activation syndrome


subject: UMLS:C5854389

object_name: idiopathic mast cell activation disorder


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: osteoarthritis


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: spinal cord glioma


subject: CHEBI:4026

object_name: brain stem glioma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Refractory Primary Amyloidosis


subject: UNII:R30772KCU0

object_name: Recurrent Primary Amyloidosis


subject: UNII:R30772KCU0

object_name: AL amyloidosis


subject: UNII:R30772KCU0

object_name: primary systemic amyloidosis


subject: UNII:R30772KCU0

object_name: Amyloid Deposition


subject: UNII:R30772KCU0

object_name: Gastrointestinal hemorrhage


subject: UNII:R30772KCU0

object_name: Early satiety


subject: UNII:R30772KCU0

object_name: Lymphadenopathy


subject: UNII:R30772KCU0

object_name: Constipation


subject: UNII:R30772KCU0

object_name: Constipation, CTCAE


subject: UNII:R30772KCU0

object_name: macroglossia


subject: UNII:R30772KCU0

object_name: congenital macroglossia


subject: UNII:R30772KCU0

object_name: Hepatomegaly


subject: UNII:R30772KCU0

object_name: diarrhea


subject: UNII:R30772KCU0

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:R30772KCU0

object_name: Diarrhea, CTCAE


subject: UNII:R30772KCU0

object_name: purpura


subject: UNII:R30772KCU0

object_name: Purpura, CTCAE


subject: UNII:R30772KCU0

object_name: Nausea, CTCAE_5


subject: UNII:R30772KCU0

object_name: Nausea


subject: UNII:R30772KCU0

object_name: Nausea, CTCAE_3


subject: UMLS:C2983777

object_name: Refractory Primary Amyloidosis


subject: UMLS:C2983777

object_name: Recurrent Primary Amyloidosis


subject: UMLS:C2983777

object_name: AL amyloidosis


subject: UMLS:C2983777

object_name: primary systemic amyloidosis


subject: UMLS:C2983777

object_name: Amyloid Deposition


subject: UMLS:C2983777

object_name: Gastrointestinal hemorrhage


subject: UMLS:C2983777

object_name: Early satiety


subject: UMLS:C2983777

object_name: Lymphadenopathy


subject: UMLS:C2983777

object_name: Constipation


subject: UMLS:C2983777

object_name: Constipation, CTCAE


subject: UMLS:C2983777

object_name: macroglossia


subject: UMLS:C2983777

object_name: congenital macroglossia


subject: UMLS:C2983777

object_name: Hepatomegaly


subject: UMLS:C2983777

object_name: diarrhea


subject: UMLS:C2983777

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C2983777

object_name: Diarrhea, CTCAE


subject: UMLS:C2983777

object_name: purpura


subject: UMLS:C2983777

object_name: Purpura, CTCAE


subject: UMLS:C2983777

object_name: Nausea, CTCAE_5


subject: UMLS:C2983777

object_name: Nausea


subject: UMLS:C2983777

object_name: Nausea, CTCAE_3


subject: CHEBI:71219

subject_name: Pazopanib

object_name: leiomyosarcoma of the corpus uteri


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: Cryptococcal meningitis


subject: UMLS:C4727714


subject: CHEBI:90227

subject_name: Selumetinib

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:90227

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:90227

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:90227

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:90227


subject: CHEBI:90227

object_name: Myelodysplasia


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Helicobacter pylori infection


subject: UMLS:C1327951

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1327951

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C1327951

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1327951

object_name: Embolism, Tumor


subject: UMLS:C1327951

object_name: Neoplasm Metastasis


subject: UMLS:C5420249

subject_name: Extended Release Metformin Hydrochloride

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5420249

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5420249

object_name: invasive breast carcinoma


subject: UMLS:C5420249

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Repeated implantation failure


subject: CHEBI:35341

subject_name: steroid

object_name: Adhesive Capsulitis


subject: CHEBI:35341

object_name: frozen shoulder


subject: CHEBI:35341

object_name: bursitis


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: mycosis fungoides


subject: UNII:YI437801BE

object_name: Sezary syndrome


subject: UNII:YI437801BE

object_name: adult T-cell leukemia/lymphoma


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: CHEMBL.COMPOUND:CHEMBL4650421

subject_name: RECOMBINANT HUMAN INTERLEUKIN-15


subject: CHEMBL.COMPOUND:CHEMBL4650421


subject: CHEMBL.COMPOUND:CHEMBL4650421


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: CHEBI:149504

object_name: Hamstring injury


subject: CHEBI:6541

subject_name: Losartan


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:5281767

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: bile duct adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: gastric adenocarcinoma


subject: UMLS:C2826161

object_name: Plasma cell myeloma refractory


subject: UNII:322ZMR6920

object_name: Atopic rhinitis


subject: UNII:322ZMR6920

object_name: Allergic Rhinitis, CTCAE


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415


subject: CHEBI:136048

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Renal cell carcinoma recurrent


subject: CHEBI:63605

object_name: Renal cancer recurrent


subject: CHEBI:63605

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:63605

object_name: clear cell renal carcinoma


subject: CHEBI:63605

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:63605

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:63605

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:63605

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:63605

object_name: Stage III renal cell cancer


subject: CHEBI:63605

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:31684

subject_name: Ibudilast

object_name: bone marrow disorder


subject: CHEBI:31684

object_name: spinal cord disorder


subject: CHEBI:31684

object_name: Myelopathy


subject: CHEBI:209807

subject_name: Cefoxitin

object_name: Neonatal infection


subject: CHEBI:209807

object_name: maternal infection during pregnancy


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:63610


subject: CHEBI:135901

subject_name: lanreotide

object_name: familial hyperinsulinism


subject: CHEBI:135901

object_name: congenital isolated hyperinsulinism


subject: UMLS:C4721901

subject_name: Lanreotide Autogel


subject: UMLS:C4721901


subject: CHEBI:567361

subject_name: Cladribine

object_name: Recurrent disease


subject: CHEBI:567361

object_name: Global Relapse in Viscera


subject: CHEBI:567361

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:567361

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:567361

object_name: Global Relapse


subject: CHEBI:567361

object_name: Global Relapse in Skin


subject: CHEBI:567361

object_name: Global Relapse in Blood


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: GTOPDB:8221

subject_name: epacadostat


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221

object_name: acute myeloid leukemia


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UMLS:C0042210

subject_name: Vaccines

object_name: sickle cell disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:1H3FW8MP4J

object_name: tuberculosis


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Fanconi anemia


subject: CHEBI:168396

object_name: Fanconi anemia complementation group A


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Postmenopausal symptoms


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C3899702

subject_name: Carrageenan-containing Gel

object_name: human papilloma virus infection


subject: CHEBI:17909

subject_name: polysulfur

object_name: scabies


subject: CHEBI:26833

subject_name: sulfur


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:KXG2PJ551I

object_name: Adult Soft Tissue Sarcoma


subject: UNII:KXG2PJ551I

object_name: sarcoma


subject: UNII:KXG2PJ551I

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:KXG2PJ551I

object_name: soft tissue sarcoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C4552025

object_name: breast carcinoma


subject: UMLS:C4552025

object_name: breast cancer


subject: UMLS:C4552025


subject: UMLS:C4552025


subject: UMLS:C4552025


subject: UMLS:C4552025


subject: UMLS:C4552025


subject: UMLS:C4552025

object_name: Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4379

subject_name: delavirdine mesylate

object_name: HIV infection


subject: CHEBI:119573

subject_name: Delavirdine


subject: PUBCHEM.COMPOUND:129130827

subject_name: Bictegravir

object_name: AIDS


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: CHEBI:15365

subject_name: Aspirin

object_name: aspirin sensitivity


subject: PUBCHEM.COMPOUND:71455937

object_name: Alport syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: anemia


subject: CHEBI:31607

object_name: Anemia, CTCAE


subject: CHEBI:58097

object_name: Addiction


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: nephrolithiasis


subject: CHEBI:94518

object_name: Staghorn calculus


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Popeye syndrome


subject: UMLS:C3896840

subject_name: magrolimab

object_name: Childhood Solid Neoplasm


subject: UMLS:C3896840

object_name: Adult Solid Neoplasm


subject: UMLS:C3896840


subject: CHEBI:60802

subject_name: ropivacaine

object_name: no feeling or sensation of skin


subject: CHEBI:60802

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Insomnia, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57505028

object_name: Insomnia, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57505028

object_name: post-traumatic stress disorder


subject: UMLS:C0008586

subject_name: Chromogranins

object_name: Surgical Wound Infection


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: cocaine use disorder


subject: PUBCHEM.COMPOUND:53477758

object_name: opiate dependence


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: GTOPDB:9757

subject_name: onfekafusp alfa

object_name: glioblastoma


subject: GTOPDB:9757

object_name: Childhood Glioblastoma


subject: GTOPDB:9757

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4298007

subject_name: ONFEKAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: UMLS:C2986395

subject_name: Fibromun


subject: UMLS:C2986395


subject: UMLS:C2986395


subject: CHEBI:70839

subject_name: Dasatinib

object_name: metastatic colorectal cancer


subject: CHEBI:190514


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: tuberculosis


subject: CHEBI:84040


subject: CHEBI:84040

object_name: severe acute respiratory syndrome


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:28747

subject_name: Picolinic acid


subject: CHEBI:28747


subject: UNII:ALO92O31SE

subject_name: Zinc picolinate


subject: UNII:ALO92O31SE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IV Renal Cell Cancer


subject: UNII:DPT0O3T46P

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Intraoperative Hemorrhage


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: type 1 diabetes mellitus 1


subject: UNII:CUJ2MVI71Y

object_name: type 1 diabetes mellitus


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered


subject: UMLS:C0919144


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: CHEBI:135609

subject_name: Gusperimus


subject: CHEBI:135609


subject: UNII:57F9XM233R

subject_name: Deoxyspergualin


subject: UNII:57F9XM233R


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: Premature Labor


subject: UMLS:C0078129


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: Benign prostatic hyperplasia with lower urinary tract symptoms


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: schizophrenia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: mal de Debarquement


subject: CHEBI:76016

object_name: Minimal Disseminated Disease


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: corneal edema


subject: PUBCHEM.COMPOUND:22227703

object_name: corneal dystrophy, Fuchs endothelial, 1


subject: PUBCHEM.COMPOUND:22227703

object_name: Fuchs' endothelial dystrophy


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:50848


subject: CHEBI:50848


subject: CHEBI:95341

subject_name: Baricitinib

object_name: juvenile dermatomyositis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: rosacea


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: MESH:D002214

subject_name: Capsules


subject: CHEBI:2922

subject_name: Auranofin

object_name: HIV infection


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Advanced Melanoma


subject: CHEBI:4026

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4026

object_name: Advanced Synovial Sarcoma


subject: CHEBI:4026

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:4026

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:4026

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4026

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:4026

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:4026

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:4026

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:4026

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:4026

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:4026

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:4026

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:4026

object_name: Metastatic synovial sarcoma


subject: CHEBI:4026

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:4026

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:4026

object_name: Unresectable Melanoma


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Advanced Melanoma


subject: CHEBI:4027

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4027

object_name: Advanced Synovial Sarcoma


subject: CHEBI:4027

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:4027

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:4027

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:4027

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:4027

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:4027

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:4027

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:4027

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:4027

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:4027

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:4027

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:4027

object_name: Metastatic synovial sarcoma


subject: CHEBI:4027

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:4027

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:4027

object_name: Unresectable Melanoma


subject: CHEBI:95165

object_name: Advanced Melanoma


subject: CHEBI:95165

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:95165

object_name: Advanced Synovial Sarcoma


subject: CHEBI:95165

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:95165

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:95165

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95165

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:95165

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:95165

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:95165

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:95165

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:95165

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:95165

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:95165

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:95165

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:95165

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:95165

object_name: Metastatic synovial sarcoma


subject: CHEBI:95165

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:95165

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:95165

object_name: Unresectable Melanoma


subject: CHEBI:95165

object_name: metastatic melanoma


subject: CHEBI:50131

subject_name: Decitabine

object_name: Advanced Melanoma


subject: CHEBI:50131

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:50131

object_name: Advanced Synovial Sarcoma


subject: CHEBI:50131

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:50131

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:50131

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:50131

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:50131

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:50131

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:50131

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:50131

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:50131

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:50131

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:50131

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:50131

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:50131

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:50131

object_name: Metastatic synovial sarcoma


subject: CHEBI:50131

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:50131

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:50131

object_name: Unresectable Melanoma


subject: CHEBI:50131

object_name: metastatic melanoma


subject: UMLS:C4549527

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Chronic hand eczema


subject: UMLS:C0745378

subject_name: intranasal drug

object_name: peripheral vertigo


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: neoplasm


subject: PUBCHEM.COMPOUND:4442

object_name: cancer


subject: CHEBI:499361

subject_name: Aprepitant


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Iron deficiency anemia of pregnancy


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:72317

object_name: breast carcinoma


subject: CHEBI:72317

object_name: breast cancer


subject: CHEBI:72317

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: HPV-related carcinoma


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: malignant glioma


subject: CHEBI:2948

subject_name: Azathioprine

object_name: acute lymphoblastic leukemia


subject: UNII:MQ5GV2WUK4

subject_name: LERAPOLTUREV

object_name: melanoma


subject: CHEBI:188074

object_name: Prediabetes


subject: CHEBI:188074

object_name: glucose intolerance


subject: CHEBI:188074

object_name: Impaired glucose tolerance


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: mucous membrane pemphigoid


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:4325

subject_name: Dapsone


subject: UMLS:C5964081

object_name: asthma


subject: UMLS:C5206629

subject_name: Multi-kinase Inhibitor TT-00420

object_name: triple-negative breast carcinoma


subject: UMLS:C5206629

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:3367

object_name: vaginal neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: vulva carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: anal margin carcinoma


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: preeclampsia


subject: UMLS:C2608320

object_name: eclampsia


subject: UMLS:C2608320

object_name: aneurysm


subject: UMLS:C2608320

object_name: cardiovascular disorder


subject: UMLS:C2608320

object_name: pre-eclamptic hypertension


subject: UMLS:C2608320

object_name: hypertension, pregnancy-induced


subject: UMLS:C2608320

object_name: toxemia of pregnancy


subject: UMLS:C2608320

object_name: pregnancy disorder


subject: UMLS:C2608320

object_name: hypertension


subject: UMLS:C2608320

object_name: Hypertension, CTCAE


subject: UMLS:C2608320

object_name: Septic Toxemia


subject: UMLS:C2608320

object_name: Bacterial Toxemia


subject: UMLS:C2608320

object_name: Sepsis


subject: UMLS:C1831949

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:177413

subject_name: Plinabulin

object_name: Chemotherapy induced neutropenia


subject: UMLS:C1741609


subject: CHEBI:4911

subject_name: Etoposide

object_name: medulloblastoma


subject: CHEBI:4911

object_name: childhood medulloblastoma


subject: CHEBI:4911

object_name: adult medulloblastoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Achalasia


subject: UMLS:C5700342

object_name: Childhood Breast Carcinoma


subject: UMLS:C5700342

object_name: breast carcinoma


subject: UMLS:C5700342

object_name: breast cancer


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: PUBCHEM.COMPOUND:25051804

subject_name: Azvudine


subject: UNII:IJ2XP0ID0K

subject_name: azvudine


subject: UMLS:C3253986

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:46058


subject: CHEBI:46058


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: coronary artery disorder


subject: CHEBI:28939

object_name: coronary atherosclerosis


subject: CHEBI:28939

object_name: kidney disorder


subject: CHEBI:28939

object_name: impaired renal function disease


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: colorectal neoplasm


subject: CHEBI:91400

subject_name: Afatinib


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:2767

object_name: malignant soft tissue neoplasm


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Neck Carcinoma


subject: CHEBI:95021

object_name: head and neck neoplasm


subject: CHEBI:95021

object_name: head and neck cancer


subject: CHEBI:95021

object_name: pancreatic neoplasm


subject: CHEBI:95021

object_name: exocrine pancreatic carcinoma


subject: CHEBI:95021

object_name: malignant pancreatic neoplasm


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021

object_name: Childhood Breast Carcinoma


subject: CHEBI:95021

object_name: breast carcinoma


subject: CHEBI:95021

object_name: breast cancer


subject: CHEBI:95021


subject: CHEBI:95021

object_name: sarcoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:131769963

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:131769963

object_name: lung cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: lung carcinoma


subject: UNII:5XYK65KIGD

object_name: Neck Carcinoma


subject: UNII:5XYK65KIGD

object_name: head and neck neoplasm


subject: UNII:5XYK65KIGD

object_name: head and neck cancer


subject: UNII:5XYK65KIGD

object_name: pancreatic neoplasm


subject: UNII:5XYK65KIGD

object_name: exocrine pancreatic carcinoma


subject: UNII:5XYK65KIGD

object_name: malignant pancreatic neoplasm


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD

object_name: prostate carcinoma


subject: UNII:5XYK65KIGD

object_name: prostate cancer


subject: UNII:5XYK65KIGD

object_name: Childhood Breast Carcinoma


subject: UNII:5XYK65KIGD

object_name: breast carcinoma


subject: UNII:5XYK65KIGD

object_name: breast cancer


subject: UNII:5XYK65KIGD

object_name: Mesothelioma


subject: UNII:5XYK65KIGD

object_name: mesothelial neoplasm


subject: UNII:5XYK65KIGD

object_name: malignant mesothelioma


subject: UNII:5XYK65KIGD

object_name: lung cancer


subject: UNII:5XYK65KIGD

object_name: lung neoplasm


subject: UNII:5XYK65KIGD

object_name: lung carcinoma


subject: CHEBI:50924

subject_name: Sorafenib

object_name: Neck Carcinoma


subject: CHEBI:50924

object_name: head and neck neoplasm


subject: CHEBI:50924

object_name: head and neck cancer


subject: CHEBI:50924

object_name: pancreatic neoplasm


subject: CHEBI:50924

object_name: exocrine pancreatic carcinoma


subject: CHEBI:50924

object_name: malignant pancreatic neoplasm


subject: CHEBI:50924

object_name: colorectal cancer


subject: CHEBI:50924

object_name: colorectal carcinoma


subject: CHEBI:50924

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:50924

object_name: prostate carcinoma


subject: CHEBI:50924

object_name: prostate cancer


subject: CHEBI:50924

object_name: Childhood Breast Carcinoma


subject: CHEBI:50924

object_name: breast carcinoma


subject: CHEBI:50924

object_name: breast cancer


subject: CHEBI:50924

object_name: Mesothelioma


subject: CHEBI:50924

object_name: mesothelial neoplasm


subject: CHEBI:50924

object_name: malignant mesothelioma


subject: CHEBI:50924

object_name: lung cancer


subject: CHEBI:50924

object_name: lung neoplasm


subject: CHEBI:50924

object_name: lung carcinoma


subject: DRUGBANK:DB05831

object_name: esophageal adenocarcinoma


subject: DRUGBANK:DB05831

object_name: lung adenocarcinoma


subject: DRUGBANK:DB05831

object_name: cervical adenocarcinoma


subject: DRUGBANK:DB05831

object_name: adenocarcinoma


subject: DRUGBANK:DB05831

object_name: bile duct adenocarcinoma


subject: DRUGBANK:DB05831

object_name: gastric adenocarcinoma


subject: CHEBI:16335

subject_name: Adenosine

object_name: migraine


subject: UMLS:C2932376

subject_name: XOMA 052

object_name: type 2 diabetes mellitus


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: plantar fibromatosis


subject: CHEBI:31684

subject_name: Ibudilast

object_name: opioid abuse


subject: CHEBI:31684

object_name: opiate dependence


subject: UMLS:C5700130


subject: UMLS:C5700130


subject: CHEBI:8378

subject_name: Prednisolone

object_name: leukemia


subject: CHEBI:8378

object_name: childhood leukemia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: adult lymphoma


subject: CHEBI:17650

object_name: lymphoma


subject: CHEBI:17650

object_name: pediatric lymphoma


subject: CHEBI:9927

subject_name: Valsartan

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:4715169

object_name: alcohol dependence


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:3219

subject_name: Bupropion

object_name: Smokeless Tobacco Exposure


subject: CHEBI:84500

subject_name: varenicline


subject: UNII:1VI94C980K

object_name: Dyslipidemia


subject: UMLS:C4079835


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: HIV infection


subject: CHEBI:8228

object_name: Insulin resistance


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: Renal transplant rejection


subject: UNII:D7RD81HE4W

object_name: TRANSPLANTS AND IMPLANTS


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hemodynamic instability


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: cervical squamous cell carcinoma


subject: UMLS:C3896806


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C0876134

subject_name: Prevnar

object_name: poliomyelitis


subject: UMLS:C0876134

object_name: pertussis


subject: UMLS:C0876134

object_name: Whooping cough


subject: UMLS:C0876134

object_name: diphtheria


subject: UMLS:C0876134

object_name: hepatitis B


subject: UMLS:C0876134

object_name: tetanus


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain


subject: UMLS:C2364569


subject: UMLS:C2364569


subject: UMLS:C2364569


subject: UMLS:C2364569


subject: UMLS:C2364569


subject: CHEBI:995

object_name: rotator cuff syndrome


subject: CHEBI:995

object_name: Rotator cuff tear


subject: UMLS:C3257792

subject_name: Bydureon

object_name: Diabetes


subject: UMLS:C3257792

object_name: diabetes mellitus


subject: UMLS:C3257792

object_name: arteriosclerosis disorder


subject: UMLS:C3257792

object_name: atherosclerosis


subject: UMLS:C3257792

object_name: Restenosis


subject: CHEBI:64073


subject: CHEBI:64073


subject: CHEBI:64073


subject: CHEBI:64073


subject: UMLS:C0139121

subject_name: SDZ PSC 833

object_name: leukemia


subject: UMLS:C0139121

object_name: childhood leukemia


subject: CHEBI:4672

subject_name: Docetaxel

object_name: prostate neoplasm


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Small cell lung cancer extensive stage


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:8988


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: Decreased liver function


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:49005

subject_name: Deferasirox

object_name: anemia


subject: CHEBI:49005

object_name: Anemia, CTCAE


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: renal pelvis/ureter urothelial carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:77590

subject_name: Armodafinil

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:77590

object_name: B-cell neoplasm


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:31859

object_name: Fatigue


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Postoperative Vasoplegic Syndrome


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:50634

object_name: obstructive sleep apnea syndrome


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UMLS:C0002007

subject_name: Aldosterone Antagonists

object_name: hypertension


subject: UMLS:C0002007

object_name: Hypertension, CTCAE


subject: UMLS:C3536833

subject_name: Aldosterone Antagonist [EPC]


subject: UMLS:C3536833


subject: UMLS:C2347903

subject_name: Recombinant Adenovirus-Interferon SCH 721015

object_name: Mesothelioma


subject: UMLS:C2347903

object_name: mesothelial neoplasm


subject: UMLS:C2347903

object_name: malignant mesothelioma


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: chronic obstructive pulmonary disease


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Drug toxicity


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: CHEBI:30145

subject_name: lithium atom

object_name: bipolar I disorder


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: CHEBI:3387

subject_name: Carbamazepine


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: Regional anesthesia morbidity


subject: UNII:9566855ULN

object_name: Acute Pain


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:6759


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Bronchiolitis, Viral


subject: CHEBI:92998

subject_name: Guanabenz

object_name: multiple sclerosis


subject: CHEBI:92998

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:16865

subject_name: Aminobutyrates

object_name: type 1 diabetes mellitus 1


subject: CHEBI:16865

object_name: type 1 diabetes mellitus


subject: UMLS:C0016904

subject_name: gamma-aminobutyric acid


subject: UMLS:C0016904


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic urothelial carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Advanced Bile Duct Carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: CHEBI:6801

subject_name: Metformin

object_name: Heart failure with normal ejection fraction


subject: CHEBI:177833

subject_name: Cilengitide

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:177833

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: CHEBI:139072

object_name: alcohol abuse


subject: CHEBI:139072

object_name: alcohol dependence


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Postoperative Residual Curarization


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:41879

object_name: atopic conjunctivitis


subject: GTOPDB:10656

subject_name: ianalumab

object_name: Sicca Syndrome


subject: UNII:ZN2GQ3II96


subject: UMLS:C3896750


subject: UNII:Z9U2SS9ZC8

object_name: plasma cell myeloma


subject: UMLS:C2703165


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: metastatic prostate carcinoma


subject: UMLS:C5226649

object_name: asthma


subject: CHEBI:3223

subject_name: Buspirone

object_name: spinal cord injury


subject: CHEBI:3223

object_name: Drug action (disorder)


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:74705

subject_name: Met-Leu

object_name: diabetic kidney disease


subject: CHEBI:74705

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:74705

object_name: obesity


subject: CHEBI:74705

object_name: Obesity, CTCAE


subject: CHEBI:74705

object_name: Weight loss


subject: CHEBI:74705

object_name: Weight Loss, CTCAE


subject: CHEBI:74705

object_name: Pediatric Obesity


subject: CHEBI:74705

object_name: bariatric surgery candidate


subject: CHEBI:74705

object_name: Complications of Diabetes Mellitus


subject: CHEBI:74705

object_name: diabetes mellitus


subject: CHEBI:74705

object_name: Adolescent Obesity


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: schizophrenia


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:90881

subject_name: Camptosar

object_name: carcinoma of esophagus


subject: CHEBI:90881

object_name: esophageal cancer


subject: CHEBI:90881

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:90881

object_name: neoplasm of esophagus


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:LKC0U3A8NJ

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:135415564

subject_name: Rifabutin

object_name: Mycobacterium avium complex disease


subject: PUBCHEM.COMPOUND:135415564

object_name: HIV infection


subject: CHEBI:45367


subject: CHEBI:45367


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Stomach cancer


subject: GTOPDB:13796

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:32188


subject: CHEBI:32188


subject: CHEBI:135915

subject_name: Thymalfasin


subject: CHEBI:135915


subject: CHEBI:135915


subject: UMLS:C3661051

object_name: Functional constipation


subject: UMLS:C3252109

subject_name: TAK 385

object_name: endometriosis


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: UMLS:C0935778

subject_name: EGFR Antisense DNA

object_name: squamous cell carcinoma


subject: UMLS:C0935778

object_name: Neck Carcinoma


subject: UMLS:C0935778

object_name: head and neck neoplasm


subject: UMLS:C0935778

object_name: head and neck cancer


subject: UMLS:C1567931

subject_name: Macugen

object_name: wet macular degeneration


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: squamous cell carcinoma of penis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: urinary tract infection


subject: UNII:6GNT3Y5LMF

object_name: Recurrent urinary tract infections


subject: UNII:6GNT3Y5LMF

object_name: bacterial infectious disease


subject: UNII:6GNT3Y5LMF

object_name: urinary system disorder


subject: UNII:6GNT3Y5LMF

object_name: bacteriuria


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:41423

subject_name: Celecoxib

object_name: cervical intraepithelial neoplasia grade 2/3


subject: CHEBI:41423

object_name: uterine cervix carcinoma in situ


subject: CHEBI:41423

object_name: Cervix Intraepithelial Neoplasia Grade 3 AJCC v7


subject: CHEBI:41423

object_name: suppressor of tumorigenicity 3


subject: CHEBI:41423

object_name: cervical carcinoma


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Childhood Solid Neoplasm


subject: GTOPDB:8313

object_name: Adult Solid Neoplasm


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:4Z63YK6E0E

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Indolent Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: MESH:C000720852


subject: MESH:C000720852

object_name: non-Hodgkin lymphoma


subject: MESH:C000720852


subject: MESH:C000720852


subject: MESH:C000720852

object_name: plasma cell myeloma


subject: MESH:C000720852


subject: MESH:C000720852


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C2928656

subject_name: halometasone / triclosan

object_name: Chronic hand eczema


subject: UNII:SE2KH7T06F

object_name: Unresectable Salivary Gland Carcinoma


subject: UNII:SE2KH7T06F

object_name: Metastatic Salivary Gland Carcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Salivary Gland Cancer


subject: UNII:SE2KH7T06F

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage III Major Salivary Gland Cancer AJCC v8


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEBI:94366

subject_name: itraconazole

object_name: Drug Interactions


subject: CHEBI:15891

subject_name: Taurine

object_name: homocystinuria


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: History of liver recipient


subject: PUBCHEM.COMPOUND:78357831

object_name: Liver transplant recipient


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Papulopustular Rosacea


subject: CHEBI:6931

subject_name: Midazolam

object_name: HIV infection


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: retinopathy of prematurity


subject: UNII:ZL1R02VT79

object_name: exudative vitreoretinopathy 1


subject: UNII:ZL1R02VT79

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:45716

subject_name: Vorinostat

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:45716

object_name: acute myeloid leukemia


subject: CHEBI:60799

subject_name: Esketamine

object_name: treatment resistant depression


subject: CHEBI:60799


subject: CHEBI:60799

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: osteoarthritis, knee


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:2PEX5N7DQ4

subject_name: Fevipiprant

object_name: asthma


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: Behcet's uveitis


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: CHEBI:141423

subject_name: Asn-Met

object_name: Renal Colic, CTCAE


subject: CHEBI:141423

object_name: renal colic


subject: UNII:R0T9LLR4TN

object_name: Wet age-related macular degeneration


subject: CHEBI:3223

subject_name: Buspirone

object_name: pervasive developmental disorder


subject: CHEBI:3223

object_name: autism


subject: CHEBI:3223

object_name: autism spectrum disorder


subject: CHEBI:3223

object_name: anxiety


subject: CHEBI:3223

object_name: anxiety disorder


subject: CHEBI:3223

object_name: Anxiety symptoms


subject: CHEBI:3223

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:3223

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: nervous system disorder


subject: CHEBI:41879

object_name: genetic disease


subject: UMLS:C3827094

subject_name: WT1 Peptide Vaccine OCV-501

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3827094

object_name: acute myeloid leukemia


subject: UMLS:C5418142

subject_name: Pyramax

object_name: malaria


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Complications of other bariatric procedure


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: CHEBI:46662

subject_name: mineral


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: Child Malnutrition


subject: PUBCHEM.COMPOUND:131674970

object_name: HIV-1 infection


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:3514


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: UMLS:C5854337

subject_name: PLS 240

object_name: secondary hyperparathyroidism


subject: UMLS:C5854337

object_name: End-stage kidney disease (ESKD)


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: progressive familial heart block, type 1A


subject: CHEBI:6888

object_name: third-degree atrioventricular block


subject: CHEBI:6888

object_name: Heart Block


subject: CHEBI:6888

object_name: Heart Block by ECG Finding


subject: CHEBI:6888

object_name: Heart block


subject: CHEBI:6888

object_name: aortic stenosis


subject: UMLS:C3661384

object_name: mucopolysaccharidosis type 4A


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: colorectal carcinoma


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Malignant neoplasm of abdomen


subject: UMLS:C0445115

object_name: Pelvic Cancer


subject: CHEBI:80961

object_name: metastatic colorectal cancer


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C3641122


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Clostridium difficile diarrhea


subject: CHEBI:6909

subject_name: Metronidazole


subject: GTOPDB:6781

subject_name: tositumomab

object_name: lymphoma, non-Hodgkin, familial


subject: GTOPDB:6781

object_name: non-Hodgkin lymphoma


subject: UNII:0343IGH41U

subject_name: TOSITUMOMAB


subject: UNII:0343IGH41U


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: CHEBI:49956

subject_name: Xenon

object_name: Cognitive impairment


subject: CHEBI:40799

subject_name: Boldione

object_name: High risk of


subject: CHEBI:40799

object_name: High risk


subject: CHEBI:40799

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: CHEBI:40799

object_name: High Risk Acute Leukemia


subject: CHEBI:40799

object_name: International Prognostic Index High Risk Group


subject: CHEBI:40799

object_name: PSA Failure


subject: UNII:4T36H88UA7

subject_name: Apalutamide


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: UNII:4T36H88UA7


subject: CHEBI:7465

subject_name: Naltrexone

object_name: borderline personality disorder


subject: CHEBI:7465

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Prolonged labor


subject: PUBCHEM.COMPOUND:160883

object_name: History of - prolonged labor


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:41423

object_name: colorectal neoplasm


subject: UMLS:C0538926


subject: UMLS:C0538926


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Recurrent Childhood Brain Neoplasm


subject: UMLS:C0919079

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:62880

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:62880

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:62880

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:62880

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:62880

object_name: Recurrent Childhood Spinal Cord Neoplasm


subject: CHEBI:62880

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:62880

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:62880

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:62880

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:62880


subject: CHEBI:62880

object_name: childhood choroid plexus neoplasm


subject: CHEBI:62880

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:62880

object_name: pediatric infratentorial ependymoma


subject: CHEBI:62880

object_name: Childhood Glioblastoma


subject: CHEBI:62880

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:62880

object_name: childhood high-grade cerebellar astrocytoma


subject: CHEBI:62880

object_name: pediatric supratentorial ependymoma


subject: CHEBI:62880

object_name: childhood low-grade cerebellar astrocytoma


subject: CHEBI:62880

object_name: Childhood Grade I Meningioma


subject: CHEBI:62880

object_name: Childhood Grade III Meningioma


subject: CHEBI:62880

object_name: Childhood Grade II Meningioma


subject: CHEBI:62880

object_name: childhood medulloepithelioma


subject: CHEBI:62880

object_name: Childhood Craniopharyngioma


subject: CHEBI:62880

object_name: childhood oligodendroglioma


subject: CHEBI:62880

object_name: pediatric cerebral ependymoblastoma


subject: CHEBI:62880

object_name: Childhood Mixed Glioma


subject: UMLS:C1568660

object_name: Childhood Breast Carcinoma


subject: UMLS:C1568660

object_name: breast carcinoma


subject: UMLS:C1568660

object_name: breast cancer


subject: UMLS:C5439002

subject_name: Influenza A virus subtype H5N1 antigen only vaccine product

object_name: influenza


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: asthma


subject: UNII:NY7PTD1862

subject_name: AXALIMOGENE FILOLISBAC

object_name: cervical adenocarcinoma


subject: UNII:NY7PTD1862

object_name: cervical adenosquamous carcinoma


subject: UNII:NY7PTD1862

object_name: cervical squamous cell carcinoma


subject: UNII:NY7PTD1862

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:NY7PTD1862

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:NY7PTD1862

object_name: Cervical carcinoma stage IVA


subject: UNII:NY7PTD1862

object_name: stage III cervical cancer


subject: UNII:NY7PTD1862

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:NY7PTD1862

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:NY7PTD1862

object_name: Cervical carcinoma stage IVB


subject: UNII:NY7PTD1862

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:NY7PTD1862

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:NY7PTD1862

object_name: cervical small cell carcinoma


subject: UNII:NY7PTD1862

object_name: Effects of immunotherapy


subject: UMLS:C2698199

subject_name: Lovaxin-C


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: UMLS:C2698199


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Renal transplant rejection


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: sinusitis


subject: CHEBI:5855

object_name: opioid abuse


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Heart Failure, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: liver cirrhosis


subject: CHEBI:176381

subject_name: Diosmin

object_name: Childhood Breast Carcinoma


subject: CHEBI:176381

object_name: breast carcinoma


subject: CHEBI:176381

object_name: breast cancer


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Liver transplant disorder


subject: UMLS:C0919144


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:35341


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:L7451S9126

subject_name: Crizanlizumab

object_name: sickle cell disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Graft Rejection


subject: UNII:4F4X42SYQ6

object_name: Immunosuppression


subject: UNII:4F4X42SYQ6

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:5100

subject_name: Flucytosine

object_name: talaromycosis


subject: CHEBI:2682

subject_name: Amphotericin B


subject: UMLS:C1442922

subject_name: Lamb antigen


subject: DRUGBANK:DB10537

subject_name: Lamb


subject: PR:000023072

subject_name: maltoporin


subject: CHEBI:149837

subject_name: Alisporivir

object_name: hepatitis C


subject: UMLS:C1567950

subject_name: alisporivir


subject: UMLS:C4053606

subject_name: Ivuxolimab

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4053606

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UNII:8GZG754X6M


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: UNII:TH2EV99S4Z

subject_name: GLASDEGIB MALEATE


subject: UNII:TH2EV99S4Z


subject: CHEBI:177425

subject_name: Patidegib

object_name: skin basal cell carcinoma


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:57505028

object_name: Diabetes


subject: PUBCHEM.COMPOUND:57505028

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:57505028

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:57505028

object_name: Menopause


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide

object_name: influenza


subject: UMLS:C0876134

subject_name: Prevnar


subject: UNII:VCW1NHW3OV

object_name: Sensory Loss


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Langerhans cell histiocytosis


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:75922

subject_name: Nepafenac

object_name: cataract


subject: CHEBI:75922

object_name: Cataract, CTCAE 3.0


subject: CHEBI:75922

object_name: Cataract, CTCAE 5.0


subject: CHEBI:75922

object_name: cataract on exam (physical finding)


subject: CHEBI:6931

subject_name: Midazolam

object_name: Adolescent Obesity


subject: UMLS:C0036557

subject_name: Sedatives


subject: UMLS:C5785765

object_name: non-small cell lung carcinoma


subject: UMLS:C5907971

subject_name: Anti-HER3 Antibody-drug Conjugate SHR-A2009


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: asthma


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:229722

subject_name: camonsertib


subject: UMLS:C5418075

subject_name: ATR Inhibitor RP-3500


subject: UNII:S1Z7Y5G56T

subject_name: CAMONSERTIB


subject: GTOPDB:8313

subject_name: talazoparib


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Problem of aging


subject: UMLS:C0002842

subject_name: Androgen Antagonists

object_name: Recurrent tumor


subject: UMLS:C0002842

object_name: salivary gland carcinoma


subject: UMLS:C0002842

object_name: salivary gland cancer


subject: UMLS:C0002842

object_name: metastatic neoplasm


subject: UMLS:C0002842

object_name: Metastatic Lesion


subject: UMLS:C5204250

subject_name: c-KIT Inhibitor


subject: UMLS:C5204250


subject: UMLS:C5204250


subject: UMLS:C5204250


subject: UMLS:C5204250


subject: UMLS:C4759996

subject_name: Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance)


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4759996


subject: UMLS:C4744354

subject_name: Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)


subject: UMLS:C4744354


subject: UMLS:C4744354


subject: UMLS:C4744354


subject: UMLS:C4744354


subject: CHEBI:28398


subject: CHEBI:28398


subject: CHEBI:28398


subject: CHEBI:28398


subject: CHEBI:28398


subject: UMLS:C0752313

subject_name: MAPK-ERK Kinases


subject: UMLS:C0752313


subject: UMLS:C0752313


subject: UMLS:C0752313


subject: UMLS:C0752313


subject: UMLS:C0169101

subject_name: Mitogen-Activated Protein Kinase Kinases


subject: UMLS:C0169101


subject: UMLS:C0169101


subject: UMLS:C0169101


subject: UMLS:C0169101


subject: UMLS:C1519050

subject_name: PI3K inhibitors


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: UMLS:C1519050


subject: CHEBI:50914

subject_name: EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:177770

subject_name: Ganetespib

object_name: neoplasm


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: UMLS:C4477356

subject_name: Culturelle 10 Billion CFU Capsule

object_name: spinal cord injury


subject: UMLS:C4477356

object_name: cauda equina syndrome with neurogenic bladder


subject: UMLS:C4477356

object_name: Neurogenic bladder


subject: CHEBI:93813

object_name: myeloproliferative neoplasm


subject: CHEBI:93813


subject: CHEBI:93813

object_name: Myelodysplasia


subject: CHEBI:93813

object_name: leukemia


subject: CHEBI:93813

object_name: childhood leukemia


subject: CHEBI:93813

object_name: adult lymphoma


subject: CHEBI:93813

object_name: lymphoma


subject: CHEBI:93813

object_name: pediatric lymphoma


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Cardiac autonomic neuropathy


subject: CHEBI:30314

object_name: type 2 diabetes mellitus


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: GTOPDB:13826

subject_name: pegcetacoplan


subject: GTOPDB:13826


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UNII:TO3JYR3BOU


subject: UNII:3W1JG795YI

subject_name: SUNFLOWER OIL

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:3W1JG795YI

object_name: obesity


subject: UNII:3W1JG795YI

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:142435949

subject_name: PIRMITEGRAVIR

object_name: HIV-1 infection


subject: UNII:3XX9YW65ZA


subject: CHEBI:6801

subject_name: Metformin

object_name: Fatty Liver


subject: PUBCHEM.COMPOUND:14907381

object_name: Human Papilloma Virus, Female


subject: PUBCHEM.COMPOUND:14907381

object_name: Human Papilloma Virus, Male


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: UMLS:C5454976

object_name: kidney failure


subject: CHEBI:170007

subject_name: Nirmatrelvir


subject: CHEBI:45409

subject_name: Ritonavir


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Stage IV Colorectal Cancer AJCC v6


subject: CHEBI:70714

subject_name: Teflaro

object_name: Infection


subject: CHEBI:70714

object_name: Infection of musculoskeletal system


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Solid Neoplasm


subject: GTOPDB:8457

subject_name: nesvacumab


subject: UNII:WX8293WGLC

subject_name: NESVACUMAB


subject: UMLS:C2987352

subject_name: Nesvacumab


subject: UMLS:C3537267


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Adult Solid Neoplasm


subject: CHEBI:91398

subject_name: Tivantinib


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:3286

subject_name: Cabergoline

object_name: adenoma


subject: CHEBI:3286

object_name: pituitary tumor


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: malignant pleural mesothelioma


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:52717

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:52717

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:52717

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:52717

object_name: anaplastic large cell lymphoma


subject: CHEBI:52717

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:52717

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:52717

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:52717

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:52717

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:52717

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:52717

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:52717

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:52717

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:52717

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:52717

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:52717

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:52717

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:52717

object_name: splenic marginal zone lymphoma


subject: CHEBI:52717

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:52717

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:52717

object_name: adult acute monocytic leukemia


subject: CHEBI:52717

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:52717

object_name: small intestine lymphoma


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:64153

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:64153

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:64153

object_name: MALT lymphoma


subject: CHEBI:64153

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:64153

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:64153

object_name: anaplastic large cell lymphoma


subject: CHEBI:64153

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma